First targeted protein degrader hits the clinic

A targeted degrader (multicoloured) binds a target (green) and an E3 ligase (blue), to drive ubiquitylation (purple) and degradation by the proteasome (orange). Credit: Arvinas.

Access options

Rent or Buy article

Get time limited or full article access on ReadCube.


All prices are NET prices.

Nature Reviews Drug Discovery 18, 237-239 (2019)

doi: https://doi.org/10.1038/d41573-019-00043-6


Nature Careers


Nature Briefing

An essential round-up of science news, opinion and analysis, delivered to your inbox every weekday.

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing